• 2024
  Leroux P, Matczak S, Bouchez V, Volant S, Ouziel A, Launay E, Faye A, Rabier V, Sarlangue J, Jeziorski E, Maakaroun-Vermesse Z, Madhi F, Pinquier D, Lorrot M, Pouletty M, Cantais A, Javouhey E, Aït Belghiti F, Guillot S, Rodrigues C, Brisse S, Cohen JF, Toubiana J, Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicenter study in France, 2008-2019., Clin Microbiol Infect 2024 Sep; (): .
• 2024
  Rodrigues C, Bouchez V, Soares A, Trombert-Paolantoni S, Aït El Belghiti F, Cohen JF, Armatys N, Landier A, Blanchot T, Hervo M, , Toubiana J, Brisse S, Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024., Euro Surveill 2024 Aug; 29(31): .
• 2023
  Soraya Matczak, Valérie Bouchez, Pauline Leroux, Thibaut Douché, Nils Collinet, Annie Landier, Quentin Giai Gianetto, Sophie Guillot, Julia Chamot-Rooke, Milena Hasan, Mariette Matondo, Sylvain Brisse, Julie Toubiana, Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype, Microbes and Infection, 2023, pp.105152. ⟨10.1016/j.micinf.2023.105152⟩.
• 2022
  Bridel S, Bouchez V, Brancotte B, Hauck S, Armatys N, Landier A, Mühle E, Guillot S, Toubiana J, Maiden MCJ, Jolley KA, Brisse S, , A comprehensive resource for Bordetella genomic epidemiology and biodiversity studies., Nat Commun 2022 Jul; 13(1): 3807.
• 2022
  Lefrancq N, Bouchez V, Fernandes N, Barkoff AM, Bosch T, Dalby T, Åkerlund T, Darenberg J, Fabianova K, Vestrheim DF, Fry NK, González-López JJ, Gullsby K, Habington A, He Q, Litt D, Martini H, Piérard D, Stefanelli P, Stegger M, Zavadilova J, Armatys N, Landier A, Guillot S, Hong SL, Lemey P, Parkhill J, Toubiana J, Cauchemez S, Salje H, Brisse S, , Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis., Sci Transl Med 2022 Apr; 14(642): eabn3253.
• 2015
  Fabre A, Dupin C, Bénézit F, Goret J, Piau C, Jouneau S, Guillot S, Mégraud F, Kayal S, Desrues B, Le Coustumier A, Guiso N, Opportunistic Pulmonary Bordetella hinzii Infection after Avian Exposure, Emerging Infect. Dis. 2015 Dec;21(12):2122-6.
• 2015
  Bouchez V, Hegerle N, Strati F, Njamkepo E, Guiso N, New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates, Vaccines (Basel) 2015;3(3):751-70.
• 2015
  Bouchez V, Guiso N, Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough, Pathog Dis 2015 Oct;73(7).
• 2015
  Tubiana S, Belchior E, Guillot S, Guiso N, Lévy-Bruhl D,, Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years’ Experience, 1996-2012, France, Pediatr. Infect. Dis. J. 2015 Aug;34(8):814-20.
• 2014
  Guiso N, Hegerle N, Other Bordetellas, lessons for and from pertussis vaccines, Expert Rev Vaccines 2014 Sep;13(9):1125-33.
• 2014
  Guiso N, Pertussis vaccination and whooping cough: and now what?, Expert Rev Vaccines 2014 Oct;13(10):1163-5.
• 2014
  Hegerle N, Guiso N, Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines, Expert Rev Vaccines 2014 Sep;13(9):1135-46.
• 2013
  Hegerle N, Guiso N, Epidemiology of whooping cough & typing of Bordetella pertussis, Future Microbiol 2013 Nov;8(11):1391-403.
• 2013
  Nguyen LB, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N, Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab, Emerging Infect. Dis. 2013 Oct;19(10):1703-5.
• 2013
  Bodilis H, Guiso N, Virulence of pertactin-negative Bordetella pertussis isolates from infants, France, Emerging Infect. Dis. 2013 Mar;19(3):471-4.
• 2012
  Guiso N, Specific biological diagnoses are needed to determine the durability of pertussis vaccine-induced immunity, Clin. Infect. Dis. 2012 Nov;55(10):1433-4; author reply 1435-6.
• 2012
  Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N, Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin, Clin. Microbiol. Infect. 2012 Sep;18(9):E340-6.
• 2012
  Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N, Macrolide-resistant Bordetella pertussis infection in newborn girl, France, Emerging Infect. Dis. 2012 Jun;18(6):966-8.
• 2011
  Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P, Rationale for pertussis booster vaccination throughout life in Europe, Lancet Infect Dis 2011 Jul;11(7):557-70.
• 2011
  Le Coustumier A, Njamkepo E, Cattoir V, Guillot S, Guiso N, Bordetella petrii infection with long-lasting persistence in human, Emerging Infect. Dis. 2011 Apr;17(4):612-8.
• 2011
  Lasserre A, Laurent E, Turbelin C, Hanslik T, Blanchon T, Guiso N, Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009, Euro Surveill. 2011;16(5).
• 2010
  Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH,, What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories, Eur. J. Clin. Microbiol. Infect. Dis. 2011 Mar;30(3):307-12.
• 2009
  Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N, First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin, Vaccine 2009 Oct;27(43):6034-41.
• 2008
  Njamkepo E, Cantinelli T, Guigon G, Guiso N, Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas, Microbes Infect. 2008 Nov-Dec;10(14-15):1582-6.
• 2008
  Guiso N, de La Rocque F, Njamkepo E, Lécuyer A, Levy C, Romain O, Thollot F, Abitbol V, Soubeyrand B, Cohen R,, Pertussis surveillance in private pediatric practices, France, 2002-2006, Emerging Infect. Dis. 2008 Jul;14(7):1159-61.
• 2008
  Bouchez V, Caro V, Levillain E, Guigon G, Guiso N, Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination, PLoS ONE 2008;3(6):e2437.
• 2008
  Caro V, Bouchez V, Guiso N, Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?, J. Clin. Microbiol. 2008 Jun;46(6):2125-8.
• 2008
  Guiso N, Bordetella pertussis polymorphism and pertussis vaccines, Clin. Vaccine Immunol. 2008 Feb;15(2):394; author reply 394-5.
• 2007
  Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Muñoz-Rivas F, Teyssou R, Guiso N, Van Rie A,, Transmission of Bordetella pertussis to young infants, Pediatr. Infect. Dis. J. 2007 Apr;26(4):293-9.
• 2006
  Guiso N, Njamkepo E, Vié le Sage F, Zepp F, Meyer CU, Abitbol V, Clyti N, Chevallier S, Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life, Vaccine 2007 Feb;25(8):1390-7.
• 2005
  Riffelmann M, Wirsing von König CH, Caro V, Guiso N,, Nucleic Acid amplification tests for diagnosis of Bordetella infections, J. Clin. Microbiol. 2005 Oct;43(10):4925-9.
• 2004
  Bassinet L, Fitting C, Housset B, Cavaillon JM, Guiso N, Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells, Infect. Immun. 2004 Sep;72(9):5530-3.
• 2004
  Dalet K, Weber C, Guillemot L, Njamkepo E, Guiso N, Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate, Infect. Immun. 2004 Aug;72(8):4874-7.
• 2003
  Gueirard P, Ave P, Balazuc AM, Thiberge S, Huerre M, Milon G, Guiso N, Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract, Infect. Immun. 2003 Jul;71(7):4137-43.
• 2003
  Hot D, Antoine R, Renauld-Mongénie G, Caro V, Hennuy B, Levillain E, Huot L, Wittmann G, Poncet D, Jacob-Dubuisson F, Guyard C, Rimlinger F, Aujame L, Godfroid E, Guiso N, Quentin-Millet MJ, Lemoine Y, Locht C, Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis, Mol. Genet. Genomics 2003 Jul;269(4):475-86.
• 2002
  Gilberg S, Njamkepo E, Du Châtelet IP, Partouche H, Gueirard P, Ghasarossian C, Schlumberger M, Guiso N, Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage, J. Infect. Dis. 2002 Aug;186(3):415-8.
• 2001
  Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N, Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years, J. Clin. Microbiol. 2001 Dec;39(12):4396-403.
• 2001
  Khelef N, Gounon P, Guiso N, Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity, Cell. Microbiol. 2001 Nov;3(11):721-30.
• 2001
  Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C, The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)., J Exp Med 2001 May; 193(9): 1035-44.
• 2000
  Boursaux-Eude C, Guiso N, Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, Infect. Immun. 2000 Aug;68(8):4815-7.
• 2000
  Bassinet L, Gueirard P, Maitre B, Housset B, Gounon P, Guiso N, Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis, Infect. Immun. 2000 Apr;68(4):1934-41.
• 2000
  Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N, Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology, Eur. J. Clin. Microbiol. Infect. Dis. 2000 Mar;19(3):174-81.
• 1999
  Grimprel E, Baron S, Lévy-Bruhl D, Garnier JM, N'jamkepo E, Guiso N, Bégué P, Influence of vaccination coverage on pertussis transmission in France, Lancet 1999 Nov;354(9191):1699-700.
• 1999
  Boursaux-Eude C, Thiberge S, Carletti G, Guiso N, Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine, Vaccine 1999 Jun;17(20-21):2651-60.
• 1999
  Guiso N, Capiau C, Carletti G, Poolman J, Hauser P, Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines, Vaccine 1999 May;17(19):2366-76.
• 1998
  Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J, Guiso N, Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination, Pediatr. Infect. Dis. J. 1998 May;17(5):412-8.
• 1998
  Simondon F, Iteman I, Preziosi MP, Yam A, Guiso N, Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal, Clin. Diagn. Lab. Immunol. 1998 Mar;5(2):130-4.
• 1997
  Simondon F, Preziosi MP, Yam A, Kane CT, Chabirand L, Iteman I, Sanden G, Mboup S, Hoffenbach A, Knudsen K, Guiso N, Wassilak S, Cadoz M, A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal, Vaccine 1997 Oct;15(15):1606-12.
• 1995
  Betsou F, Sismeiro O, Danchin A, Guiso N, Cloning and sequence of the Bordetella bronchiseptica adenylate cyclase-hemolysin-encoding gene: comparison with the Bordetella pertussis gene, Gene 1995 Aug;162(1):165-6.
• 1995
  Gueirard P, Weber C, Le Coustumier A, Guiso N, Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host, J. Clin. Microbiol. 1995 Aug;33(8):2002-6.
• 1993
  Gueirard P, Guiso N, Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin, Infect. Immun. 1993 Oct;61(10):4072-8.
• 1993
  Khelef N, Zychlinsky A, Guiso N, Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin, Infect. Immun. 1993 Oct;61(10):4064-71.
• 1993
  Betsou F, Sebo P, Guiso N, CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin, Infect. Immun. 1993 Sep;61(9):3583-9.
• 1992
  Khelef N, Sakamoto H, Guiso N, Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection, Microb. Pathog. 1992 Mar;12(3):227-35.
• 1991
  Guiso N, Szatanik M, Rocancourt M, Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization, Microb. Pathog. 1991 Dec;11(6):423-31.
• 1989
  Guiso N, Rocancourt M, Szatanik M, Alonso JM, Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen, Microb. Pathog. 1989 Nov;7(5):373-80.
• 1986
  Ladant D, Brezin C, Alonso JM, Crenon I, Guiso N, Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay, J. Biol. Chem. 1986 Dec;261(34):16264-9.